Skip to main content
Premium Trial:

Request an Annual Quote

Patent Trouble

Genentech has accused the University of Pennsylvania of committing "patent fraud," reports The Daily Pennsylvanian's Laura Cofsky. The company is suing the school over a cancer treatment they both say is theirs, Cofsky says. Penn tested the treatment on transgenic mice engineered to develop cancer, and accused Genentech of patent infringement when the school noticed a patent from the company for the same treatment. Genentech then filed a counter complaint in May 2012, and is now suing, Cofsky says. "Furthermore, according to court documents, Genentech also believes Penn is misrepresenting its patent, alleging that Penn inaccurately reported both the life expectancy and final population size of their lab mouse test group," she adds. The company isn't asking for monetary damages, but for the court to declare Penn's patent invalid.

(HT: Pharmalot's Ed Silverman)

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.